OLN-93
Cell line · Product number 305848
OLN-93 is a permanent oligodendroglial cell line derived from primary glial cultures of neonatal rat brain. The cell line originated from spontaneously tr...
Recommended (freshest lot)
01General information
- Description
OLN-93 is a permanent oligodendroglial cell line derived from primary glial cultures of neonatal rat brain. The cell line originated from spontaneously transformed cells in mixed glial cultures and was characterized to maintain stable oligodendroglial properties over extended culture periods. OLN-93 cells proliferate continuously in the presence of serum, with a doubling time of approximately 16-18 hours, and retain key features of differentiated oligodendrocytes. Immunocytochemical and biochemical analyses demonstrate that these cells express major myelin-specific markers including galactocerebroside (GC), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), proteolipid protein (PLP), and Wolfgram protein (WP). The expression of PLP and its alternatively spliced isoform DM20 has been confirmed at the mRNA level using RT-PCR.
Importantly, OLN-93 cells do not express the astrocytic markers vimentin and glial fibrillary acidic protein (GFAP), nor the oligodendrocyte precursor marker A2B5, indicating a differentiated, non-precursor phenotype. Morphologically, the cells exhibit a bipolar appearance under standard culture conditions and develop arborized processes when grown at low density or in low-serum environments, resembling immature or early postnatal oligodendrocytes. These characteristics make OLN-93 a valuable model for studying oligodendrocyte differentiation, myelin protein expression, and interactions with neurons or other glial cell types in vitro.
OLN-93 cells have also been genetically engineered to study neurodegenerative disease processes. For instance, when transfected to express human α-synuclein (including the A53T mutant) and tau protein, they serve as a model to investigate mechanisms of protein aggregation under stress. Upon exposure to oxidative and proteasomal stress, OLN-93 cells form thioflavin S-positive aggregates that co-localize with α-synuclein, tau, and αB-crystallin, resembling glial cytoplasmic inclusions seen in synucleinopathies such as multiple system atrophy. These stress-induced changes in protein solubility and aggregate composition underline OLN-93’s utility as a model system to explore proteostasis, chaperone biology, and the cellular responses of oligodendrocytes to pathological protein aggregation.
- Tissue
- Brain
- Synonyms
- OLN93
- OLN 93
02Classification
- Organism
- Rat
- Sex
- Unspecified
- Growth properties
- Adherent
03Characteristics
- Cell type
- Oligodendrocyte
04Identifiers
- Citation
- OLN-93 (Cytion catalog number 305848)
- NCBI TaxID
- 10116
- Cellosaurus
- CVCL_5850
05Handling and culture
- Culture medium
- DMEM, w: 4,5 g/L Glucose, w: 4 mM L-Glutamin, w: 3,7 g/L NaHCO3, w: 1,0 mM Natriumpyruvat, 10% FBS
- Incubation atmosphere
37°C, 5% CO2, humidified atmosphere.
- Supplements
- Supplement the medium with 10% FBS
- Dissociation reagent
- Accutase 5 min 37°C
- Seeding density
- 1-3 x 104 cells/cm2
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
06Quality control and cryopreservation
- Sterility
Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.
To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.
- Freeze medium
- As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
- Storage conditions
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Shipping conditions
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
07Donor
- Donor age
- 1 day
08Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Disclaimer
- Our cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes
